AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma
AHSA1 是多发性骨髓瘤细胞增殖和蛋白酶体抑制剂耐药的一个有希望的治疗靶点
期刊:Journal of Experimental & Clinical Cancer Research
影响因子:11.4
doi:10.1186/s13046-021-02220-1
Chunyan Gu #, Yajun Wang #, Lulin Zhang #, Li Qiao #, Shanliang Sun, Miaomiao Shao, Xiaozhu Tang, Pinggang Ding, Chao Tang, Yuhao Cao, Yanyan Zhou, Mengjie Guo, Rongfang Wei, Nianguang Li, Yibei Xiao, Jinao Duan, Ye Yang